Category: ALung Technologies Inc.Syndicate content

Senseonics gains funding for continuous glucose monitoring implant | Medtech funding for the week of June 2, 2014

June 6, 2014 by MassDevice

Here's a look at some of the top funding stories for medical device companies this week: Diabetes: Senseonics raises $20M for continuous glucose monitoring implant; ALung raises $10M for Hemolung; Premia Spine confirms $7M raise for spinal fusion alternative; Spinal Kinetics reels in $34M, settles patent spat with DePuy Synthes; TAVI: Transcatheter Technologies lands 2nd Series B tranche.

Diabetes: Senseonics raises $20M for continuous glucose monitoring implant

June 5, 2014 by Arezu Sarvestani

ALung raises $10M for Hemolung

May 30, 2014 by Brad Perriello

ALung Technologies raises another $10 million for its Hemolung respiratory assist device.

ALung raises $10M for Hemolung

ALung Technologies said it drummed up another $10 million it plans to use to continue commercializing its Hemolung respiratory assist device.

Pittsburgh-based ALung's Hemolung device is an extracorporeal carbon dioxide removal system that works by removing carbon dioxide and delivering oxygen directly to a patient's blood via a small catheter inserted into the jugular or femoral vein.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

FDA panel: 30-year-old ECMO therapy should be reclassified to lower-risk Class II

September 13, 2013 by Ingrid Mezo

An FDA advisory panel recommends reclassifying extracorporeal membrane oxygenator therapy from the highest-risk category to the less-risky Class II designation.

FDA panel: 30-year-old ECMO therapy should be reclassified to lower-risk Class II

An FDA panel yesterday recommended that the FDA reclassify membrane lung for long-term pulmonary support systems, or so-called extracorporeal membrane oxygenator circuits and accessories, from the highest-risk Class III category to the less burdensome Class II, with special controls.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

ALung breathes easy with $16M funding round

September 11, 2013 by Brad Perriello

ALung Technologies raises a nearly $16 million Series B1 round for its Hemolung respiratory assist device.

ALung breathes easy with $16M funding round

ALung Technologies said it raised a $15.8 million Series B1 round it plans to use to accelerate the commercialization of its Hemolung respiratory assist device.

The Pittsburgh-based medical device company said the round was led by Allos Ventures and included West Capital Partners, Birchmere Ventures, BlueTree Capital Group, PLSG Accelerator Fund, Smithfield Trust Company and several private investors.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

ALung nears close of $17M equity funding round

July 22, 2013 by Arezu Sarvestani

ALung inches closer to topping off a $17 million fundraising round, with less than $2.3 million left to raise.

ALung Technologies logo

Pennsylvania medical device maker ALung Technologies is nearing the close of a $17 million equity funding round with about $14.7 million raised so far among 48 unnamed investors, according to an SEC filings.

The new report updated a fundraising effort that began in late March 2013, and ALung reported last month that it had hit the $9.5 million mark in the raise. Now it's got about 2.3 million left before putting a bow on this round.

ALung pulls in $9.5M, aims for $7.5M more

June 21, 2013 by Brad Perriello

ALung pulls in $9.5 million in an equity funding round it hopes will eventually bring in a total of $17 million for its Hemolung respiratory assist system.

ALung pulls in $9.5M, aims for $7.5M more

ALung Technologies raised $9.5 million of a hoped-for $17 million for its Hemolung respiratory assist system, according to a regulatory filing.

The Pittsburgh-based medical device company is aiming to get the Hemolung device on the market here and in China.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp